SUNFLOWER(SZ:300111) Sou Hu Cai Jing·2026-01-19 08:05Group 1 - The company Sunflower (300111) has received a notice from the China Securities Regulatory Commission (CSRC) regarding a formal investigation due to suspected violations of information disclosure laws [2] - Investors who purchased the stock between September 22, 2025, and December 25, 2025, and held it after the market closed on December 25, 2025, are eligible to apply for compensation for their losses [2] Group 2 - The company announced the termination of its plan to acquire 100% equity of Zhangzhou Xipu Materials Technology Co., Ltd. and 40% equity of Zhejiang Beid Pharmaceutical Co., Ltd. through a share issuance and cash payment [4] - The CSRC's inquiry highlighted that Xipu Materials, based in Fujian Zhangzhou, has no actual production capacity at its factories in Zhangzhou and Lanzhou, despite being a core supplier for several wafer fabs [4] - The inquiry also requested detailed information on Xipu Materials' production capacity, including the status of approvals, construction, and production at its factories [4] Group 3 - Xipu Materials is primarily engaged in the research, manufacturing, and sales of high-end semiconductor materials, with core products including high-purity electronic gases and silicon-based precursors [5] - The inquiry requested financial details regarding Xipu Materials' revenue, costs, and gross margins for 2023 and 2024, as well as information on its transactions with Shanghai Deen Hong New Materials Technology Co., Ltd. [5] - Concerns were raised about potential adverse impacts on competition and independence due to the restructuring, as well as the legal issues faced by Xipu Materials' actual controller, which could affect asset transfers [5]